After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Spyre Therapeutics Inc is $1.24B. A total of 0.95 million shares were traded on the day, compared to an average of 570.61K shares.
In the most recent transaction, Albers Jeffrey W. sold 6,700 shares of SYRE for 36.76 per share on Nov 06 ’24. After the transaction, the Director now owns 27,360 company shares. In a previous transaction on Oct 25 ’24, Albers Jeffrey W. sold 300 shares at 36.43 per share. SYRE shares that Director owns now total 34,060.
Among the insiders who bought shares, SESSIONS, LLC acquired of 7,000 shares on Oct 25 ’24 at a per-share price of $33.70. In another insider transaction, Burrows Scott L sold 18,531 shares at $28.17 per share on Sep 03 ’24. Company shares held by the Chief Financial Officer now total 116,422.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SYRE has a high of $47.97 and a low of $17.24.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SYRE’s latest balance sheet shows that the firm has $93.13M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $20.14M in liabilities at the time. Its Book Value Per Share was $6.01, while its Total Shareholder’s Equity was $83.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SYRE is Buy with a score of 4.83.
